Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Syncom Formulations Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

67/100
13.59
0.15 (1.12%)

As on 17 Feb, 2026 | 11:07

Open Trading A/c
Day Range
13.33
13.78
L H
52 Week Range
11.65
23.49
L H
Volume
458,135
*
i

* BSE Market Depth (17 Feb 2026)

BUY SELL
QTY PRICE PRICE QTY
100 13.60 13.62 868
1629 13.59 13.65 837
2192 13.56 13.66 2377
500 13.55 13.67 600
94 13.54 13.71 552
131661 Total Total 99615
Bid / Ask
13.60 / 13.62
67/100
13.56
0.00 (0.00%)

As on 17 Feb, 2026 | 11:07

Open Trading A/c
Day Range
13.33
13.78
L H
52 Week Range
11.52
23.46
L H
Volume
62,239
*
i

* BSE Market Depth (17 Feb 2026)

BUY SELL
QTY PRICE PRICE QTY
100 13.60 13.62 868
1629 13.59 13.65 837
2192 13.56 13.66 2377
500 13.55 13.67 600
94 13.54 13.71 552
131661 Total Total 99615
Bid / Ask
13.60 / 13.62
NSE
MC Essentials
71% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, High Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 13.44
          Previous Close 13.44
          Volume 454,936.00
          Value (Lacs) 61.87
            VWAP 13.61
          Beta
          Mkt Cap (Rs. Cr.) 1,278
          High 13.78
          Low 13.33
          UC Limit 16.12
          LC Limit 10.76
          52 Week High 23.49
          52 Week Low 11.65
          Face Value 1.00
          All Time High 27.90
          All Time Low 4.60
          20D Avg Volume 1,961,931
          20D Avg Delivery(%) 46.56
          Book Value Per Share 4.03
          Dividend Yield 0.00
          TTM EPS See historical trend 0.73 (+75.31% YoY)
          TTM PE See historical trend 18.63 (Low PE)
          P/B See historical trend 3.38 (Average P/B)
          Sector PE 39.12

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          67/100
          Average Financial Strength, High Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 42.06% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 50.57% in Dec 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          3 out of 4 years Syncom Formulations has given negative returns in February.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          February 4.71% 4.71% -20.51% (2023) -15.35% -10.34%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Syncom Formula

          What's your call on Syncom Formula today?

          Read 10 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          09 Sep, 2024

          Hrti Private Limited

          Qty 8536197 Price 25.26 % Traded 0.86
          09 Sep, 2024

          Hrti Private Limited

          Qty 8150466 Price 25.14 % Traded 0.81
          09 Sep, 2024

          Graviton Research Capital Llp

          Qty 7106640 Price 24.86 % Traded 0.70
          09 Sep, 2024

          Graviton Research Capital Llp

          Qty 7106640 Price 24.91 % Traded 0.70
          06 Sep, 2024

          Graviton Research Capital Llp

          Qty 5329278 Price 23.42 % Traded 0.57
          06 Sep, 2024

          Graviton Research Capital Llp

          Qty 5329278 Price 23.46 % Traded 0.58
          06 Sep, 2024

          Hrti Private Limited

          Qty 5094857 Price 23.4 % Traded 0.55
          06 Sep, 2024

          Hrti Private Limited

          Qty 4707047 Price 23.37 % Traded 0.51

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Syncom Formulations (India) Ltd. is engaged in the business of pharmaceutical formulations. The company manufactures range of products in various dosage forms and markets them in various countries. In addition to pharmaceutical formulations in the form of tablets, capsules, liquids and dry powders, the company also manufactures Injectibles, inhalers and ear/eye drops.The product range of the company includes Generic-Tablets,Capsules,Liquid Orals,Vials,Eye / Ear Drops,Ampoules and Dry Powder Orals.Herbal Branded-Colo Vaporex,Colo Inhaler,Colo Mouth Gel,Fastac Ointment,Candid Balm,Saloni Cream,Borosyn Cream,Edicare Cream,Ecziguard Cream,Pyl Gel,Attom Cream,Attom Megacaps,Shilajit Capsules,Liovset Tonic,Colo Cough Syrup,Pudin Rahat,Syncom Gripe Water,Feelax Powder and Yas Antacid Salt.Branded Allopathic-Qudermis Cream,Silver Plus Cream,Aciril Tablets,Fastac tablets,Odynil Tablets,Palera Plus Tablets,Polyfer Tablets 50 mg,Polyfer tablets 100 mg,Syncal D Tablets,M - Dox DT Tablets,Synortin Tablets,Synospas Tablets,Tici Forte Tablets,Triple Action Tablets,Flusa Kit Tablets,HBC kit (Combikit of 4 Tablets),NTB-4 Kit Tablets,Fresca Tablets,etc.
          {"success":1,"data":{"address":{"address1":"7, Niraj Industrial Estate,","address2":"Off Mahakali Caves Road,,Andheri (East),","city":"Mumbai","state":"Maharashtra","pincode":"400093","telephone1":"022-26877700","telephone2":"022-26877711","fax1":"022-30887755","fax2":"","email":"finance@sfil.in","web":"http:\/\/www.sfil.in"},"management":[{"name":"Ankit Kedarmal Bankda","designation":"Executive Chairman & Whole-time Director"},{"name":"Vijay Shankarlal Bankda","designation":"Managing Director"},{"name":"Kedarmal Shankarlal Bankda","designation":"Whole Time Director"},{"name":"Ruchi Jindal","designation":"Independent Woman Director"},{"name":"Ritesh Kumar Lunkad","designation":"Independent Director"}],"registrars":{"name":"Ankit Consultancy Pvt. Ltd.","address1":"60, Electronic Complex,","address2":"Pardeshipura,,","address3":"","address4":"","telephone":"0731-2551745, 2551746","fax":"","email":"ankit_4321@yahoo.com","internet":"","city":"Indore","state":"Madhya Pradesh","pincode":"452010"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524470","nseId":"SYNCOMF","series":"EQ","isinid":"INE312C01025"}}}
          • Registered Office

            • Address

              7, Niraj Industrial Estate,,Off Mahakali Caves Road,,Andheri (East),

            • City

              Mumbai

            • State

              Maharashtra

            • Pin Code

              400093

            • Tel. No.

              022-26877700

            • Fax No.

              022-30887755

            • Email

              finance@sfil.in

            • Internet

              http://www.sfil.in

          • Registrars

            • Address

              60, Electronic Complex,,Pardeshipura,,

            • City

              Indore 452010

            • State

              Madhya Pradesh

            • Tel. No.

              0731-2551745, 2551746

            • Fax No.

            • Email

              ankit_4321@yahoo.com

            • Internet

          • Management

            • Ankit Kedarmal Bankda

              Executive Chairman & Whole-time Director

            • Vijay Shankarlal Bankda

              Managing Director

            • Kedarmal Shankarlal Bankda

              Whole Time Director

            • Ruchi Jindal

              Independent Woman Director

            • Ritesh Kumar Lunkad

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524470

            • NSE:

              SYNCOMF

            • Series

              EQ

            • ISIN

              INE312C01025

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
          Close Parallel Income Plan 2026